Canton Strategic (CNTN) vs Innate Pharma S.A. (IPHA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Innate Pharma S.A. (IPHA) has outperformed Canton Strategic (CNTN) over the past year, losing 22.1% versus a loss of 25.2%. Canton Strategic is the larger company by market cap ($165.7 million vs $165.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTN | IPHA |
|---|---|---|
| Share price | $2.08 | $1.48 |
| Market cap | $165.74M | $165.32M |
| 1-day change | -7.96% | -2.63% |
| YTD return | -25.41% | -13.14% |
| 1-year return | -25.17% | -22.05% |
| 5-year return | — | -74.11% |
| EPS (TTM) | $-0.10 | $-0.59 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.89 | $2.71 |
| 52-week low | $1.75 | $1.17 |
| Distance from 52-week high | -69.81% | -45.39% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +350.68% |
| Average volume | 751.76K | 156.71K |
| Shares outstanding | 79.68M | 111.70M |
| Employees | 12 | 120 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About Innate Pharma S.A.
IPHA stock →Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 120 employees
CNTN vs IPHA FAQ
Which is bigger, Canton Strategic or Innate Pharma S.A.?
Canton Strategic (CNTN) is larger, with a market capitalization of $165.74M compared with $165.32M for Innate Pharma S.A. (IPHA).
Which stock has performed better over the past year, CNTN or IPHA?
IPHA returned -22.05% over the past 12 months, compared with -25.17% for CNTN (price return, excluding dividends). Past performance does not predict future results.
Are Canton Strategic and Innate Pharma S.A. in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Canton Strategic and Biotechnology: Biological Products (No Diagnostic Substances) for Innate Pharma S.A..